News

October 24, 2014October 24, 2014

Phase I SBIR Grant Awarded to Radiomedix and Viewpoint MT For Metastatic Melanoma Theranostics

News

RadioMedix, Inc. and Viewpoint Molecular Targeting LLC have been awarded a grant by the Small Business Innovation Research (SBIR) program from the National Cancer Institute. This Phase I award of ... Read more

October 23, 2014October 23, 2014

Study Finds New Subpopulation of Melanoma Cells

News

In a recent study titled “Vascular channels formed by subpopulations of PECAM1+ melanoma cells”, published in Nature Communications, a team of researchers from the University of North Carolina School of Medicine, ... Read more

October 22, 2014October 22, 2014

Study Links Melanoma Thickness To Patient Death Rates

News

Researchers from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, have published a study in the Journal of Investigative Dermatology, titled “More people die from thin melanomas (<1mm) than thick melanomas ... Read more

October 21, 2014October 21, 2014

Study Shows DecisionDx-Melanoma Is An Accurate Gene Expression Profile Test

News

A study presented at the annual meeting of the American Society for Clinical Oncology has shown that DecisionDx-Melanoma (Castle Biosciences), a commercially available gene expression-profile (GEP) test, can be a useful ... Read more

October 20, 2014October 20, 2014

New Melanoma Drug Combination Improves Patient Survival Rate, According To Study

News

A recent study titled “Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma”, and presented at the 2014 European Society for Medical Oncology (ESMO) conference in Madrid, Spain, showed that patients with advanced ... Read more

October 20, 2014October 20, 2014

Melanoma Patients Often Carry TERT Promoter Mutations

Melanoma, News

A group at University Hospital Essen in German confirmed the commonality of mutations in the gene for telomerase reverse transcriptase (TERT) in patients with cutaneous melanoma through a new study ... Read more

October 17, 2014October 17, 2014

SIRT6 Is Not Protective In Skin Cancer

News, Skin Cancer

“One cancer’s threat is another cancer’s promoter” is the theme of a new study published in Cancer Research by the laboratory of Yu-Ying He, PhD, in the Department of Medicine, ... Read more

October 16, 2014

Melanoma Treatment Benefits From Injecting Oncolytic Viruses

News

Research presented at the European Society for Medical Oncology (ESMO) Congress 2014, Madrid, Spain, has revealed that oncolytic viruses, such as specific common cold or herpes simplex viruses, can have ... Read more

October 15, 2014October 15, 2014

Melanoma Cells Use LPA Gradient to Migrate Around Body

Melanoma, News

As melanoma is one of the fastest spreading, aggressive cancer types, researchers are constantly trying to understand melanoma cells in order to stop their spread in the body. At the ... Read more

October 14, 2014October 14, 2014

Understanding Mutations, micro-RNAs, and Melanoma at Toldeo University

Melanoma, News, Skin Cancer

At University of Toledo, the laboratories of Drs. Kam Yeung and Ivana de la Serna discovered a new explanation for aggressive melanoma. Ila Datar, a PhD graduate student in the ... Read more

October 10, 2014October 10, 2014

Intense Focus on Melanoma At The ESMO 2014

News

The Presidential Symposium and the poster sessions at the European Society for Medical Oncology (ESMO) 2014 were mostly focused on melanoma studies. The meeting was held in Madrid, Spain, where ... Read more

October 9, 2014October 9, 2014

Studies Suggest Efficacy of Intralesional Injections for Melanoma Therapy

News

Three presentations during the “Melanoma and Other Skin Tumors” poster session at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid highlighted the efficacy of treating cutaneous melanoma ... Read more

October 8, 2014October 8, 2014

Provectus To Present PV-10 Clinical Data At The 2014 Beijing International Melanoma Congress

News

Provectus Biopharmaceuticals, Inc., a company specializing in developing oncology and dermatology therapies, has announced that clinical data on its investigative new drug PV-10 for the treatment of melanoma will be ... Read more

October 7, 2014

New Gigapixel High-Definition Camera For Skin Cancer Diagnosis

News

A team of researchers at Duke University in North Carolina, USA, have developed a gigapixel whole-body photographic camera capable of taking snapshots of the entire human body, enabling the caption ... Read more

October 6, 2014

Melanoma Incidence Linked to Socioeconomic Factors and Fashion Trends According to Study

News

A new study published in the American Journal of Public Health titled “More Skin, More Sun, More Tan, More Melanoma”, links cultural and historical forces to the increased incidence of ... Read more

October 3, 2014

Roche And GSK Melanoma Drug Combination Shows Similar Results

News

Results from recent clinical trials presented at the European Society of Medical Oncology annual congress in Madrid, showed that two of the new pill combinations for melanoma treatment from Roche ... Read more

October 2, 2014

Experimental Therapy Shows Promising Results in Melanoma

News

During the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, data from a clinical study assessing pembrolizumab for the treatment of melanoma showed promising activity and safety profiles. ... Read more

October 1, 2014October 1, 2014

Melanoma, Immunotherapy-Radiation Combination Therapy Continues To Show Promise

News

A new study addressing the effect of highly focused radiation in boosting the immune system to target and kill cancer cells upon combination with a novel type of immune-enhancing drug, was presented ... Read more

September 30, 2014September 30, 2014

Array’s Melanoma Drug Promising in Phase 2 Study

Melanoma, News

Array BioPharma Inc. recently presented the latest results of its Phase 2 clinical trial of binimetinib in patients with advanced NRAS mutant melanoma, at the European Society for Medical Oncology (ESMO) Annual Meeting ... Read more